Abstract
Workflow solutions driven by data pipelining are increasingly becoming popular for accessing, aggregating and analyzing disparate data to make informed and intelligent decisions. Uses of workflow technologies which facilitate business intelligence (BI) improve productivity, decision making and research efficiency. In order to provide BI in a scientific or clinical based organization, it is imperative that the application or workflow technology must be compatible with multiple data types and formats, be able to analyze the data and make it available throughout the organization. We term this as Scientific Business Intelligence (SBI) and discuss how modeling, simulations and informatics software, integrated with open and standards-based scientific operating platform (SOP), can deliver scientifically-relevant BI solutions. We illustrate SBI with several examples encompassing all levels of users within an organization.
Keywords: Scientific business intelligence, data pipelining, workflows, web deployment, data integration, dashboard, Pipeline Pilot™
Current Computer-Aided Drug Design
Title: Changing Paradigms in Drug Discovery: Scientific Business Intelligence™ and Workflow Solutions
Volume: 4 Issue: 1
Author(s): Shikha Varma-O'Brien, Frank K. Brown, Andrew LeBeau and Robert D. Brown
Affiliation:
Keywords: Scientific business intelligence, data pipelining, workflows, web deployment, data integration, dashboard, Pipeline Pilot™
Abstract: Workflow solutions driven by data pipelining are increasingly becoming popular for accessing, aggregating and analyzing disparate data to make informed and intelligent decisions. Uses of workflow technologies which facilitate business intelligence (BI) improve productivity, decision making and research efficiency. In order to provide BI in a scientific or clinical based organization, it is imperative that the application or workflow technology must be compatible with multiple data types and formats, be able to analyze the data and make it available throughout the organization. We term this as Scientific Business Intelligence (SBI) and discuss how modeling, simulations and informatics software, integrated with open and standards-based scientific operating platform (SOP), can deliver scientifically-relevant BI solutions. We illustrate SBI with several examples encompassing all levels of users within an organization.
Export Options
About this article
Cite this article as:
Varma-O'Brien Shikha, Brown K. Frank, LeBeau Andrew and Brown D. Robert, Changing Paradigms in Drug Discovery: Scientific Business Intelligence™ and Workflow Solutions, Current Computer-Aided Drug Design 2008; 4 (1) . https://dx.doi.org/10.2174/157340908783769274
DOI https://dx.doi.org/10.2174/157340908783769274 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin and Hypothalamic-Pituitary-Gonadal Axis
Current Medicinal Chemistry Characterization of Phosphorylated Proteins Using Mass Spectrometry
Current Protein & Peptide Science CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?
Current Signal Transduction Therapy Effectiveness and Safety of Digoxin on Chronic Heart Failure
Current Pharmaceutical Analysis The Two Faces of Protein Palmitoylation in Islet β-Cell Function: Potential Implications in the Pathophysiology of Islet Metabolic Dysregulation and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Dedicated Breast CT: Current Status and New Directions
Current Medical Imaging Novel Strategies in the Ablation of Typical Atrial Flutter: Role of Intracardiac Echocardiography
Current Cardiology Reviews microRNAs: Innovative Targets for Cerebral Ischemia and Stroke
Current Drug Targets Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Isometric Handgrip Effects on Hypertension
Current Hypertension Reviews HIV/AIDS: Recent Advances in Antiretroviral Agents
Mini-Reviews in Medicinal Chemistry Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Probing Cerebrovascular Alterations in Alzheimers Disease Using MRI: From Transgenic Models to Patients
Current Medical Imaging Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Clinical Presentation, Diagnostic Work-Up, and Treatment of Coronary In-Stent Restenosis
Vascular Disease Prevention (Discontinued) Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets Pharmacokinetics and Pharmacodynamics of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor
Current Clinical Pharmacology Expression Microarray Proteomics and the Search for Cancer Biomarkers
Current Genomics Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update
Current Pharmaceutical Design